DevicePMAs@therightstef:P150005_S035 JSON TXT

Annnotations TAB JSON ListView MergeView

PMA_MER

consensus_PMA_Age_Indications

{"project":"consensus_PMA_Age_Indications","denotations":[{"id":"T2","span":{"begin":561,"end":572},"obj":"age_range"},{"id":"T5","span":{"begin":561,"end":563},"obj":"age_start"},{"id":"T7","span":{"begin":567,"end":572},"obj":"age_end"},{"id":"T3","span":{"begin":685,"end":702},"obj":"age_range"},{"id":"T4","span":{"begin":685,"end":687},"obj":"age_start"},{"id":"T6","span":{"begin":688,"end":693},"obj":"age_start_unit"},{"id":"T8","span":{"begin":697,"end":702},"obj":"age_end"}],"text":"Approval for expanded indications for use to include the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation. The devices, as modified, will be marketed under the trade name IntellaTip MiFi Open-Irrigated Ablation Catheter and IntellaNav MiFi Open-Irrigated Ablation Catheter when used with a compatible Radiofrequency Controller and Irrigation Pump, are indicated for cardiac electrophysiological mapping, delivering diagnostic pacing stimuli, radiofrequency ablation of sustain or recurrent Type 1 Atrial Flutter in patients age 18 or older, and treatment of drug refractory, recurrent, symptomatic, paroxysmal atrial fibrillation (PAF) in patients age 18 years or older, when used with a compatible mapping system."}

age_PMA_annotations

{"project":"age_PMA_annotations","denotations":[{"id":"T1","span":{"begin":561,"end":563},"obj":"population"},{"id":"T2","span":{"begin":685,"end":687},"obj":"population"}],"text":"Approval for expanded indications for use to include the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation. The devices, as modified, will be marketed under the trade name IntellaTip MiFi Open-Irrigated Ablation Catheter and IntellaNav MiFi Open-Irrigated Ablation Catheter when used with a compatible Radiofrequency Controller and Irrigation Pump, are indicated for cardiac electrophysiological mapping, delivering diagnostic pacing stimuli, radiofrequency ablation of sustain or recurrent Type 1 Atrial Flutter in patients age 18 or older, and treatment of drug refractory, recurrent, symptomatic, paroxysmal atrial fibrillation (PAF) in patients age 18 years or older, when used with a compatible mapping system."}

Age_blah

{"project":"Age_blah","denotations":[{"id":"T4","span":{"begin":561,"end":563},"obj":"age_start"},{"id":"T5","span":{"begin":567,"end":572},"obj":"age_end"},{"id":"T6","span":{"begin":561,"end":572},"obj":"age_range"},{"id":"T7","span":{"begin":685,"end":687},"obj":"age_start"},{"id":"T8","span":{"begin":697,"end":702},"obj":"age_end"},{"id":"T9","span":{"begin":685,"end":702},"obj":"age_range"}],"text":"Approval for expanded indications for use to include the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation. The devices, as modified, will be marketed under the trade name IntellaTip MiFi Open-Irrigated Ablation Catheter and IntellaNav MiFi Open-Irrigated Ablation Catheter when used with a compatible Radiofrequency Controller and Irrigation Pump, are indicated for cardiac electrophysiological mapping, delivering diagnostic pacing stimuli, radiofrequency ablation of sustain or recurrent Type 1 Atrial Flutter in patients age 18 or older, and treatment of drug refractory, recurrent, symptomatic, paroxysmal atrial fibrillation (PAF) in patients age 18 years or older, when used with a compatible mapping system."}

PMA_age_indications

{"project":"PMA_age_indications","denotations":[{"id":"T5","span":{"begin":561,"end":563},"obj":"age_start"},{"id":"T2","span":{"begin":561,"end":572},"obj":"age_range"},{"id":"T7","span":{"begin":567,"end":572},"obj":"age_end"},{"id":"T4","span":{"begin":685,"end":687},"obj":"age_start"},{"id":"T3","span":{"begin":685,"end":702},"obj":"age_range"},{"id":"T6","span":{"begin":688,"end":693},"obj":"age_start_unit"},{"id":"T8","span":{"begin":697,"end":702},"obj":"age_end"}],"text":"Approval for expanded indications for use to include the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation. The devices, as modified, will be marketed under the trade name IntellaTip MiFi Open-Irrigated Ablation Catheter and IntellaNav MiFi Open-Irrigated Ablation Catheter when used with a compatible Radiofrequency Controller and Irrigation Pump, are indicated for cardiac electrophysiological mapping, delivering diagnostic pacing stimuli, radiofrequency ablation of sustain or recurrent Type 1 Atrial Flutter in patients age 18 or older, and treatment of drug refractory, recurrent, symptomatic, paroxysmal atrial fibrillation (PAF) in patients age 18 years or older, when used with a compatible mapping system."}

updated_tagging_age_PMA_annotations

{"project":"updated_tagging_age_PMA_annotations","denotations":[{"id":"T2","span":{"begin":561,"end":572},"obj":"age_range"},{"id":"T3","span":{"begin":685,"end":702},"obj":"age_range"},{"id":"T4","span":{"begin":685,"end":687},"obj":"age_start"},{"id":"T5","span":{"begin":561,"end":563},"obj":"age_start"},{"id":"T6","span":{"begin":688,"end":693},"obj":"age_start_unit"},{"id":"T7","span":{"begin":567,"end":572},"obj":"age_end"},{"id":"T8","span":{"begin":697,"end":702},"obj":"age_end"}],"text":"Approval for expanded indications for use to include the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation. The devices, as modified, will be marketed under the trade name IntellaTip MiFi Open-Irrigated Ablation Catheter and IntellaNav MiFi Open-Irrigated Ablation Catheter when used with a compatible Radiofrequency Controller and Irrigation Pump, are indicated for cardiac electrophysiological mapping, delivering diagnostic pacing stimuli, radiofrequency ablation of sustain or recurrent Type 1 Atrial Flutter in patients age 18 or older, and treatment of drug refractory, recurrent, symptomatic, paroxysmal atrial fibrillation (PAF) in patients age 18 years or older, when used with a compatible mapping system."}